Search clinical trials for: EPITOME-1

Total 46914 results

UCB Pharma
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Healthy Volunteers

Germany
Genzyme, a Sanofi Company

Completed

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery. (C-MUST)

Adhesion Prevention

France
JKT Biopharma Co., Ltd.

Recruiting

The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects

Phase 1

China
Graviton Bioscience Corporation

Completed

Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects

Phase 1

United States
The University of Hong Kong

Not yet recruiting

The Effect of TPS on Cognitive Functions in Older Adults With MCI

Mild Cognitive Impairment
Children's Hospital of Fudan University

Recruiting

Three Dietary Regimens in Pre-colonoscopic Bowel Preparation in Children

Bowel Preparation

China
Assiut University

Not yet recruiting

COPD Scoring Systems in ICU (crosssectional)

COPD Scoring System

Egypt
UCB Pharma SA
Parexel

Completed

A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects

Healthy Subjects

China
UCB Korea Co., Ltd.
Seoul Pharma Laboratories Inc.

Completed

Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects

Healthy

Korea, Republic of
UCB Pharma SA

Terminated

Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease (REFRESH-PD)

Advanced Idiopathic Parkinson's Disease

United Kingdom
Conor Medsystems

Terminated

CoStar Catheter System Evaluation (CONCISE)

Symptomatic Ischemic Heart Disease

Germany
Xu J

Recruiting

New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA

Obstructive Sleep Apnea

China
Chita State Regional Clinical Hospital Number 1

Recruiting

Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 (SPIDEX-II)

Coronavirus Infection | Pneumonia, Viral

Russian Federation
Azienda U.S.L. 1 di Massa e Carrara

Completed

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2016)

Post Partum Haemorrhage

Italy
Wu Wenjun-1
Xidian University

Unknown

Real-time NIRS Neurofeedback Regulating Brain Cognitive Function in Obese Individuals

Obesity | Neurofeedback

China
Yaounde Central Hospital
University of Yaounde 1

Completed

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

Hypertension | Diabetes Mellitus, Type 2

Cameroon
National University of Singapore

Recruiting

Exploration of Women's Experiences and Technology Usage Before, During, and After Pregnancy in Singapore

Pregnancy Related

Singapore
Eli Lilly and Company

Recruiting

A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)

Dyslipidemias | Non-Alcoholic Fatty Liver Disease

United States
Sanofi

Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, Canada, Czechia, France, Hungary, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom
Thomayer University Hospital
Masaryk University

Recruiting

Czech AATD Registry

Alpha-1-antitrypsin Deficiency

Czechia
Reproductive Medicine Associates of New Jersey

Completed

Evaluation of the Impact of Embryo Biopsy on the Reproductive Potential of Embryos Undergoing In Vitro Fertilization (IVF)

Each Patient is Both Case and Control | 1 Embryo Will be Biopsied and 1 Embryo is Not

United States
Rambam Health Care Campus
Hadassah Medical Organization; Tel-Aviv Sourasky Medical Center; Soroka University...

Completed

α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD (AATGVHD-MARK)

GVHD | Bone Marrow Transplant Failure | Alpha 1-Antitrypsin

Israel
Universitat Autonoma de Barcelona
Ministerio de Economía y Competitividad, Spain

Recruiting

Efficacy of iMentalize and MISC-SA to Foster Parents' Mentalization and Children Mental Health in General Population. (iMentalize)

Mental Health Wellness 1 | Social Interaction | Emotional Intelligence | Well-Being, Psychological

Spain
SinoMab BioScience Ltd

Recruiting

A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects

1. Asthma

United States
Eastern Mediterranean University
Ege University

Completed

Effect of an Exercise on Serum Uncoupling Protein-1 Level and the Role of Uncoupling Protein-1-3826 A/G Polymorphism

Polymorphism, Restriction Fragment Length | Irisin | Uncoupling Protein-1

Turkey
Canadian Immunodeficiency Research Collaborative
Hoffmann-La Roche

Completed

Fuzeon Viral Decay Pilot Study

HIV-1

Canada
Apokus AS
Norwegian Pharmacy Association

Recruiting

Effects of Medisinstart for Type 2 Diabetes

Type 2 Diabetes

Norway
Peking University

Not yet recruiting

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Gastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
Yale University
National Institute of Mental Health (NIMH)

Completed

The Momba Mobile Application-based Community (MOMBA)

Mental Health Wellness 1

United States
Eli Lilly and Company

Recruiting

A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants

Healthy

China
Eli Lilly and Company

Recruiting

A Study of LY3873862 in Healthy Participants

Healthy

United Kingdom
Eli Lilly and Company

Active, not recruiting

A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

Healthy | Alzheimer Disease

United States, Japan
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

Obesity | Overweight

Spain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial (SUMMIT)

Obesity | Heart Failure With Preserved Ejection Fraction (HFpEF)

China, United States, Taiwan, Mexico, Brazil, Puerto Rico, Argentina, Israel, India, Russian Federation
Eli Lilly and Company

Active, not recruiting

A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis (RESOLUTION-1)

Immune System Diseases | Autoimmune Diseases | Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Connective Tissue Diseases | Rheumatoid Arthritis

United States, Spain, China, Mexico, Puerto Rico, Japan, Canada, Argentina, Poland, Hungary, Greece
Eli Lilly and Company

Active, not recruiting

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

Ulcerative Colitis

Spain, United States, China, Australia, Austria, Japan, Hungary, Taiwan, Russian Federation, Canada, Korea, Republic of, Italy, Belgium, Poland, Switzerland, Argentina, India, Israel, Latvia, Ukraine, Denmark, Mexico, Romania, Malaysia, Netherland... and more
Eli Lilly and Company

Active, not recruiting

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer (postMONARCH)

Neoplasm Metastasis | Breast Neoplasm

United States, Hungary, Italy, Czechia, Taiwan, Turkey, Belgium, Spain, Korea, Republic of, Israel, Argentina, Greece, France, Mexico, Sweden, Denmark, Poland
Eli Lilly and Company

Active, not recruiting

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)

Type 2 Diabetes | T2D

United States, Mexico, Argentina, Puerto Rico
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) (SURPASS-SWITCH)

Type 2 Diabetes

United States, Belgium, Germany, Mexico, Romania
Eli Lilly and Company

Active, not recruiting

A Study of LY3561774 in Participants With Mixed Dyslipidemia (PROLONG-ANG3)

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hyperlipoproteinemia

United States, Mexico, Poland, Canada, Turkey, Japan, Argentina
Eli Lilly and Company

Completed

A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes (RescuiNGkids)

Type 1 Diabetes

United States
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events (KRAKEN)

Lipoprotein Disorder

Australia, China, Hungary, Brazil, Japan, Germany, Netherlands, United States
Eli Lilly and Company

Completed

A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia

Hypertriglyceridemia

Singapore
Eli Lilly and Company

Active, not recruiting

A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities

Obesity | Overweight

China
Eli Lilly and Company

Completed

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Diabetes Mellitus, Type 2

India
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

Diabetes Mellitus, Type 2 | Type 2 Diabetes

United States
Loxo Oncology, Inc.
Eli Lilly and Company

Active, not recruiting

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)

Medullary Thyroid Cancer

United States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
Eli Lilly and Company

Completed

A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

China
Eli Lilly and Company

Completed

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Healthy | Renal Insufficiency

United States

Search clinical trials for: EPITOME-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations